Your trial.
Our solutions.
.png)
.png)
We have never failed to deliver to a study
Clinical trials supplied
1,200+
Suppliers and manufacturers
200+
Years of global experience
150+
Our Services
We manage the entire clinical supply chain
Case Study
Oncology Trial
Supplying a leading Biotech’s global Phase 3 study
Challenge
To supply a Phase 3 high value oncology product trial spanning 14 countries within eight weeks and to ensure regular resupply for three years
Solution
CSI’s manufacturer relationships and depot network ensured high volumes of ruxolitinib were sourced and delivered on time
Result
Efficient supply of the product allowed scheduled Site Initiation Visits (SIVs) to take place, keeping the Biotech’s study on track
Our Expertise
Six areas in which CSI excels
North America
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
Canada
Guatemala
Mexico
Panama
United States
EMEA
Austria
Belgium
Bulgaria
Croatia
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Greece
Hungary
Ireland
Israel
Italy
Jordan
Latvia
Lebanon
Lithuania
Netherlands
Norway
Oman
Poland
Portugal
Romania
Russia
Saudi Arabia
Serbia
Slovakia
Slovenia
South Africa
Spain
Sweden
Switzerland
Tunisia
Turkey
United Arab Emirates
United Kingdom
South America
Argentina
Brazil
Colombia
Peru
Asia Pacific
Australia
China
India
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Global Reach
Warehouses
Offices
CSI's sourcing capabilities are served by an extensive network of audited manufacturers and suppliers, strategically positioned across 60 countries on six continents
Our Global Reach
Warehouses and offices
Our network extends to 60 countries on six continents
Our Partners
Why work with us?
Pharmaceutical and Biotechnology Companies
CSI is a proud supplier to top-ten pharmaceutical companies and leading biotechs around the world, providing tailor-made solutions and country-specific regulatory expertise to boost success rates for even the most complex global trials
Clinical Research Organisations (CROs)
Along with our smart sourcing solutions and unrivalled product access, we manage the entire supply chain, allowing CROs to concentrate on finding patients and delivering successful clinical trials – saving time, money and resources
The Rise of GLP-1 Therapies and What It Means for Clinical Supply
Over the past few years, GLP-1 receptor agonists have moved from a niche diabetes treatment to one of the most in-demand drug classes globally. Medicines such as semaglutide and tirzepatide are now widely used not only for type 2 diabetes but increasingly for obesity and metabolic disease. Demand Is Outpacing Supply Global demand for GLP-1 therapies has surged due to increased global trial activity involving GLP-1 comparators, expanding indications and it’s increasing availability to the...
Cold Chain Logistics: Safeguarding Comparator Integrity in Clinical Trials
Cold-chain logistics play a pivotal role in pharmaceutical supply, ensuring patient safety and trial continuity. This is especially true in the oncology sector, where most therapies are temperature-sensitive and in high demand, amplifying the need for robust cold-chain infrastructure. Cold-chain logistics refers to the temperature-controlled transport and storage of pharmaceutical products. For biologics, cell and gene therapies and many oncology medications, maintaining a narrow temperature...
Mastering Customs, Imports & Exports
The movement of investigational medicinal products (IMPs) and comparators across borders can be a complex undertaking with customs regulations, import/export requirements, and VAT considerations. CSI supports its clients by removing this complexity and ensuring that clinical supplies move efficiently, compliantly and without delay. Global expertise, local execution Our team has extensive experience navigating country-specific regulations, documentation requirements, and import/export...
Navigating Global Trade Uncertainty in Clinical Trials
Understanding the Impact of Tariffs on Clinical Trials Recent headlines about proposed US tariffs on European countries highlight the volatility of the global trade environment. As reported this week in Fierce Pharma , potential new duties on several European nations raise questions about the future of US–EU trade relations. This uncertainty can significantly impact the pharmaceutical industry. For sponsors running global clinical trials, this kind of uncertainty translates into real...
Case Study: Humira Cost Savings Through Biosimilar Access
Client: Mid-size biotech conducting multiple clinical trials Challenge: The client required a large quantity of Humira (adalimumab) for several upcoming studies. High costs and limited availability were putting pressure on study budgets and timelines. Solution: CSI leveraged its industry insight and direct relationships with the manufacturer to provide access to a high-quality adalimumab biosimilar. This saved the client a staggering 50% on price. By carefully coordinating sourcing and...
Celebrating the Holiday Season with Clinical Services International (CSI)
A Message of Joy and Gratitude From all of us at Clinical Services International (CSI), we wish you a joyful and peaceful holiday season! As we reflect on the past year, we are filled with gratitude for the incredible partnerships, teamwork, and milestones we have achieved together. This season is a time for celebration and appreciation. Special Christmas Video To commemorate this special time, we have created a heartfelt Christmas video. This video highlights the remarkable journey we have...
The Twelve Days of Christmas!
On the 12th day of Christmas CSI gave to me… Twelve reasons sponsors trust CSI, all year long! On the 1st day of Christmas CSI gave to me… Direct Manufacturer Access! Receive faster timelines and documentation thanks to CSI’s direct accounts with global pharma leaders. Reach out to CSI for a sourcing consultation, no matter how big or small your request. On the 2nd day of Christmas CSI gave to me… Unmatched sustainability; with an EcoVadis Platinum rating, putting us in the top 1% of...
Preparing Your Comparator Strategy for 2026: Risks, Realities and Solutions
As we prepare for Q1 2026, sponsors and CROs face a shifting global landscape for clinical trial comparator sourcing that focuses on sustainability, diversity and fair pricing. With our EcoVadis Platinum certification, women-owned business status and full scientific team in place, CSI is well placed to support our partner’s supply chains. 1. Supply-chain volatility is real Clinical supplies are increasingly challenged by geo-political pressures, export controls, and manufacturing...
CSI Empowers Clinical Trials as a Women-Owned Business
By Clinical Services International As a proud Women-Owned Business , Clinical Services International (CSI) is committed to transforming the global clinical supply landscape while championing gender equity and social responsibility. Founded on the principles of scientific excellence, ethical sourcing and diversity, CSI stands at the forefront of pharmaceutical procurement and supply solutions for clinical trials worldwide. Women-owned businesses are vital to the global economy, bringing...
Case Study: Global Sourcing of Opdivo (Nivolumab) for an Oncology Study
Client Overview A global biopharmaceutical company approached CSI to support a Phase III oncology study requiring Opdivo (nivolumab) as a comparator. The study spanned 4 countries across North America, Europe and Asia-Pacific, with a target enrolment of over 500 patients. The client’s main objective was to ensure timely delivery of branded Opdivo for multiple trial sites while maintaining transparent, full chain of custody and documentation. Challenge There were several key sourcing...
.png){kind=logo}